临床试验

Magseed Pro(R)/ Sentimag(R) Gen3

NCT：NCT05142787 · RECRUITING

NCT编号NCT05142787

状态RECRUITING

开始日期2023-03-02

完成时间2028-06-30

SponsorEndomagnetics Ltd. (INDUSTRY)

First posted2021-12-03

Last updated2026-09-16

简要摘要

The purpose of this study is to provide prospective evidence that the Magseed Pro® marker /Sentimag® Gen3 system is safe and effective for marking A. suspicious/biopsy-proven positive axillary lymph nodes; and B. soft tissue lesions including cancer and pre-cancerous change in the breast

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。